Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Theillet

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Breast Cancer Research : BCR|June 4, 2010
What do we learn from HER2-positive breast cancer genomic profiles?Charles Theillet
Bioinformatics (Oxford, England)|March 16, 2013
Modeling risk stratification in human cancerThierry Rème, Dirk Hose, Charles Theillet, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical dataElodie Chartron, Charles Theillet, Séverine Guiu, et al.
Cancers|July 2, 2021
Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?Esin Orhan, Carolina Velazquez, Imene Tabet, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Involvement of ATM missense variants and mutations in a series of unselected breast cancer casesCarmen Rodriguez, Hélène Vallès, Annick Causse, et al.
Critical Reviews in Oncology/Hematology|September 28, 2013
Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancerPierre-Emmanuel Colombo, Michel Fabbro, Charles Theillet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Snail and slug play distinct roles during breast carcinoma progressionChristophe Côme, Fabrice Magnino, Frédéric Bibeau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcomeCarmen Rodriguez, Luke Hughes-Davies, Hélène Vallès, et al.
BMC Cancer|March 7, 2007
A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR studyMaïa Chanrion, Hélène Fontaine, Carmen Rodriguez, et al.
Molecular Biosystems|October 16, 2012
Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cellsAnne Saumet, Guillaume Vetter, Manuella Bouttier, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Breast Cancer Research : BCR|June 4, 2010
What do we learn from HER2-positive breast cancer genomic profiles?Charles Theillet
Bioinformatics (Oxford, England)|March 16, 2013
Modeling risk stratification in human cancerThierry Rème, Dirk Hose, Charles Theillet, et al.
Critical Reviews in Oncology/Hematology|January 22, 2019
Targeting homologous repair deficiency in breast and ovarian cancers: Biological pathways, preclinical and clinical dataElodie Chartron, Charles Theillet, Séverine Guiu, et al.
Cancers|July 2, 2021
Regulation of RAD51 at the Transcriptional and Functional Levels: What Prospects for Cancer Therapy?Esin Orhan, Carolina Velazquez, Imene Tabet, et al.
Genes, Chromosomes & Cancer|January 17, 2002
Involvement of ATM missense variants and mutations in a series of unselected breast cancer casesCarmen Rodriguez, Hélène Vallès, Annick Causse, et al.
Critical Reviews in Oncology/Hematology|September 28, 2013
Sensitivity and resistance to treatment in the primary management of epithelial ovarian cancerPierre-Emmanuel Colombo, Michel Fabbro, Charles Theillet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Snail and slug play distinct roles during breast carcinoma progressionChristophe Côme, Fabrice Magnino, Frédéric Bibeau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
Amplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcomeCarmen Rodriguez, Luke Hughes-Davies, Hélène Vallès, et al.
BMC Cancer|March 7, 2007
A new molecular breast cancer subclass defined from a large scale real-time quantitative RT-PCR studyMaïa Chanrion, Hélène Fontaine, Carmen Rodriguez, et al.
Molecular Biosystems|October 16, 2012
Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cellsAnne Saumet, Guillaume Vetter, Manuella Bouttier, et al.
Pageof 6